The KRW 43 billion ‘Vytorin Tab’ market is noticed by 23 generic products
Domestic pharmaceutical companies have kept eyes on the hyperlipidemia treatment ‘Vytorin Tab’ market, which used to worth KRW 43 billion last year.
According to the Ministry of Food and Drug Safety, 12 pharmaceutical companies in Korea have acquired approvals for 23 ‘Vytorin Tab(ezetimibe+simva...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
